Big business pockets $17 billion a year from pesticides that cost 430 Australian lives and $5.3 billion in disease and death.

Australia's pesticide trade adds A$17 billion a year to farm production, a number the industry commissioned and publishes. Australians pay A$5.3 billion a year for the damage: Parkinson's disease, lymphoma and other blood cancers, prostate and bowel cancer, and IQ loss in children that stays with them for life. The industry pays none of it. And the A$5.3 billion is the tip of the iceberg: it counts only the harm strong enough to model.

Of the roughly 15,700 Australians those diseases kill every year, the model attributes about 430 to pesticide exposure. Paraquat alone multiplies the risk of Parkinson's disease two and a half times. It is still sold in Australia. The regulator kept it in June 2026, at the end of a review that ran for thirty years.

Nobody ever paid to count the cost, so we counted it ourselves: an endpoint-level model, built entirely on published epidemiology and official valuation figures. It lands at A$5.3 billion a year, about A$510 for every household in the country. The full-transfer build reaches A$13 billion. This is the price of the blindness our earlier investigation documented: Australia tests almost none of its domestic food, never samples its people, and no longer even tracks what it sprays.

The industry's levies fund the regulator that approves the chemicals. The damage the chemicals do is billed to hospitals, to employers, to families, and to the people who die. An economist calls that an externality. A plainer word is a transfer: the profits are private and the invoice is public.